FORMULATION, CHARACTERIZATION AND DETERMINATION OF ANTIBACTERIAL ACTIVITY OF POMEGRANATE (Punica granatum) GEL.
Afendi Dahlan, Mohd Asyraf Mohd Razali
Department of Pharmaceutics, Faculty of Pharmacy, Cyberjaya University College of Medical Sciences, Lot 3410 Jalan Teknokrat 3, Cyberjaya 63000, Selangor, Malaysia
Keywords: Antibacterial Activity, Pomegranate (Punica Granatum)
Abstract

Purpose. Previous studies have shown that Punica granatum (P. granatum) extract exhibited antimicrobial activity against a wide range of pathogenic microorganisms. Thus, the aim of study was to formulate and determine the effectiveness of antimicrobial properties of gel containing P. granatum methanol extract against selected common skin pathogens including Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa and Candida albicans. Methods. Extraction process utilizes P. granatum peel and methanol as solvent. Using the disc diffusion method, different concentrations (25 %w/v, 50 %w/v, 75 %w/v and 100 %w/v) of P. granatum extract were initially tested against S. aureus, S. epidermidis, P. aeruginosa and C. albicans for their antibacterial activity. Gel formulations were then prepared with varying concentration of the extract as active ingredient. Antimicrobial activity of P. granatum gel was determined by using agar well diffusion method. The gel formulations were stored at 4°C, 25°C and 37°C for one month. Evaluation on the pH, physical characteristic and antimicrobial activity were then conducted on the gel formulations. Results. Both extract and gel showed highest antibacterial activity against S. epidermidis followed by S. aureus and then P. aeruginosa. Surprisingly no antifungal activity was observed against C. albicans. The concentration of extract alone and in gel were directly proportional to antibacterial activity. All gels formulated showed satisfactory physical characteristics even after a month of storage at different temperature. As expected, gel stored at 4°C showed the least decrease in antibacterial activity. Conclusions. P. granatum has potential to be formulated as gel to treat bacterial skin infection caused by S. aureus, S. epidermidis and P. aeruginosa. Further studies are required in order to optimize the antimicrobial activity of P. granatum gel.

Article Information

Identifiers and Pagination:
Year:2015
Volume:7
First Page:13
Last Page:23
Publisher Id:19204159.7:1.2015
Article History:
Received:October 21,2014
Accepted:November 11,2014
Collection year:2015
First Published:January 1, 2015


© 2016 The Author(s). This open access article is distributed under a Creative Commons Attribution (CC-BY) 4.0 license. You are free to: Share — copy and redistribute the material in any medium or format Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
Editor in Chief
Prof. Dr. Cornelia M. Keck (Philipps-Universität Marburg)
Marburg, Germany

Bibliography

Welcome to the research group of Prof. Dr. Cornelia M. Keck in Marburg. Cornelia M. Keck is a pharmacist and obtained her PhD in 2006 from the Freie Universität (FU) in Berlin. In 2009 she was appointed as Adjunct Professor for Pharmaceutical and Nutritional Nanotechnology at the University Putra Malaysia (UPM) and in 2011 she obtained her Venia legendi (Habilitation) at the Freie Universität Berlin and was appointed as a Professor for Pharmacology and Pharmaceutics at the University of Applied Sciences Kaiserslautern. Since 2016 she is Professor of Pharmaceutics and Biopharmaceutics at the Philipps-Universität Marburg. Her field of research is the development and characterization of innovative nanocarriers for improved delivery of poorly soluble actives for healthcare and cosmetics. Prof. Keck is executive board member of the German Association of Nanotechnology (Deutscher Verband Nanotechnologie), Vize-chairman of the unit „Dermocosmetics“ at the German Society of Dermopharmacy, active member in many pharmaceutical societies and member of the BfR Committee for Cosmetics at the Federal Institute for Risk Assessment (BfR).

Journal Highlights
Abbreviation: J App Pharm
doi: http://dx.doi.org/10.21065/19204159
Frequency: Annual 
Current Volume: 9 (2017)
Next scheduled volume: December, 2018 (Volume 10)
Back volumes: 1-9
Starting year: 2009
Nature: Online 
Submission: Online  
Language: English

Subject & Scope
  • Pharmaceutics
  • Physical Pharmacy 
  • Dosage Forms Science 
  • Pharmaceutical Microbiology & Immunology 
  • Industrial Pharmacy 
  • Bio-Pharmaceutics 
  • Pharmaceutical Chemistry 
  • Pharmaceutical Instrumentation 
  • Medicinal Chemistry 
  • Pharmacognosy 
  • Physiology &Histology 
  • Anatomy & Pathology 
  • Pharmacology & Therapeutics 
  • Pharmacy Practice 
  • Pharmaceutical Mathematics   
  • Biostatistics 
  • Dispensing 
  • Community Social & Administrative Pharmacy 
  • Hospital Pharmacy 
  • Clinical Pharmacy 
  • Pharmaceutical Quality Management 
  • Forensic Pharmacy 
  • Pharmaceutical Technology 
  • Pharmaceutical Management & Marketing

Consortium Publisher is an online publisher that enjoys global presence with International Journals

Follow Us

©2009 - 2019 Consortium Publisher Canada

Contact Info

6252 Lisgar Dr Mississauga Ontario L5N7V2 Canada
+1 (647) 526-0885
office@consortiumpublisher.ca
http://www.consortiumpublisher.ca/